SCHEMBL14083082

SCHEMBL14083082

COc1cc(C(=O)Nc2ccnc(Cl)c2)ccc1-c1ncccc1C(F)(F)F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 10/20 0.57
▸ MAPT P10636 3/20 0.48
▸ LMNA P02545 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ POLB P06746 1/20 0.47
▸ HDAC4 P56524 1/20 0.46
▸ AURKB Q96GD4 1/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SCN5A Q14524 1/20 0.44
▸ SCN9A Q15858 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ RORC P51449 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083069 0.89 TRPV1 (0.60) TRPV1MAPTLMNAGAAMEN1
SCHEMBL14083071 0.89 MAPT (0.63) TRPV1MAPTLMNAGAAMEN1
SCHEMBL14083068 0.88 TRPV1 (0.64) TRPV1MAPTLMNAGAAPOLB
SCHEMBL14083315 0.88 POLB (0.52) MAPTLMNAGAAPOLBAURKB
SCHEMBL14083080 0.88 KCNQ3 (0.59) TRPV1
SCHEMBL14083086 0.87 TRPV1 (0.63) TRPV1MAPTLMNAGAAPOLB
SCHEMBL14084124 0.87 TRPV1 (0.57) TRPV1HDAC4SCN5ASCN9A
SCHEMBL14083064 0.87 TRPV1 (0.65) TRPV1MAPTLMNAPOLBAURKB
SCHEMBL14083808 0.87 POLB (0.51) TRPV1MAPTLMNAPOLBAURKB
SCHEMBL14083066 0.85 TRPV1 (0.58) TRPV1MAPTLMNAGAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885MAPT 2822/4885LMNA 2619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback